Cite
Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anaemia and Impaired Renal function (REPAIR-IDA): rationale and study design.
MLA
Szczech, Lynda A., et al. “Randomized Evaluation of Efficacy and Safety of Ferric Carboxymaltose in Patients with Iron Deficiency Anaemia and Impaired Renal Function (REPAIR-IDA): Rationale and Study Design.” Nephrology Dialysis Transplantation, vol. 25, no. 7, July 2010, pp. 2368–75. EBSCOhost, https://doi.org/10.1093/ndt/gfq218.
APA
Szczech, L. A., Bregman, D. B., Harrington, R. A., Morris, D., Butcher, A., Koch, T. A., Goodnough, L. T., Wolf, M., & Onken, J. E. (2010). Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anaemia and Impaired Renal function (REPAIR-IDA): rationale and study design. Nephrology Dialysis Transplantation, 25(7), 2368–2375. https://doi.org/10.1093/ndt/gfq218
Chicago
Szczech, Lynda A., David B. Bregman, Robert A. Harrington, David Morris, Angelia Butcher, Todd A. Koch, Lawrence T. Goodnough, Myles Wolf, and Jane E. Onken. 2010. “Randomized Evaluation of Efficacy and Safety of Ferric Carboxymaltose in Patients with Iron Deficiency Anaemia and Impaired Renal Function (REPAIR-IDA): Rationale and Study Design.” Nephrology Dialysis Transplantation 25 (7): 2368–75. doi:10.1093/ndt/gfq218.